MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Corcept Therapeutics Incorporated EBITDA per Share 2011-2026 | CORT
Annual EBITDA per Share Corcept Therapeutics Incorporated
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.33 | 1.05 | 1.07 | 1.09 | 1.12 | 0.995 | 0.778 | 0.467 | 0.0928 | -0.0308 | -0.272 | -0.415 | -0.39 | -0.388 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.33 | -0.415 | 0.464 |
Quarterly EBITDA per Share Corcept Therapeutics Incorporated
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 0.04 | - | - | 0.29 | - | - | 0.14 | - | 0.3 | 0.3 | 0.26 | - | 0.32 | 0.27 | 0.17 | - | 0.22 | 0.31 | 0.33 | - | 0.29 | 0.22 | 0.17 | - | 0.2 | 0.18 | 0.18 | - | 0.12 | 0.11 | 0.04 | - | 0.03 | 0.01 | 0.01 | - | - | -0.01 | -0.04 | - | -0.05 | -0.06 | -0.13 | - | -0.1 | -0.11 | -0.11 | - | -0.08 | -0.09 | -0.13 | - | -0.08 | -0.11 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.33 | -0.13 | 0.0922 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Adagene
ADAG
|
-0.63 | $ 1.7 | 11.11 % | $ 95.7 M |  China |
 |
AstraZeneca PLC
AZN
|
0.74 | $ 95.05 | 0.42 % | $ 96.9 B |  Britain |
 |
Autolus Therapeutics plc
AUTL
|
-0.92 | $ 1.6 | -11.64 % | $ 408 M | Britain |
 |
Alterity Therapeutics Limited
ATHE
|
-1.68 | $ 3.53 | 0.14 % | $ 8.49 B |  Australia |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B |  USA |
 |
AgeX Therapeutics
AGE
|
-9.04 K | - | -10.17 % | $ 12.2 K | USA |
 |
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M |  France |
 |
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | USA |
 |
Biogen
BIIB
|
4.62 | $ 183.04 | -2.44 % | $ 26.7 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | Britain |
 |
BioNTech SE
BNTX
|
62.6 | $ 100.16 | 0.31 % | $ 27.2 B | Germany |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.01 | $ 4.1 | -0.97 % | $ 8.92 B |  Israel |
 |
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
-8.25 | $ 205.63 | 1.3 % | $ 5 B |  Danmark |
 |
Catalyst Pharmaceuticals
CPRX
|
1.65 | $ 22.6 | -0.53 % | $ 2.68 B | USA |
 |
ARCA biopharma
ABIO
|
-5.25 | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
-1.38 | - | 4.01 % | $ 150 M |  Canada |
 |
Crinetics Pharmaceuticals
CRNX
|
-4.16 | $ 55.0 | 3.28 % | $ 4.44 B | USA |
 |
CRISPR Therapeutics AG
CRSP
|
-5.3 | $ 54.77 | 1.73 % | $ 4.62 B |  Schweiz |
 |
Catalyst Biosciences
CBIO
|
-1 | $ 10.78 | -0.14 % | $ 710 M | USA |
 |
Cytokinetics, Incorporated
CYTK
|
-4.7 K | $ 60.85 | -2.66 % | $ 6.81 M | USA |
 |
DBV Technologies S.A.
DBVT
|
-1.17 | $ 17.69 | 4.0 % | $ 1.72 B | France |
 |
Adaptimmune Therapeutics plc
ADAP
|
-0.11 | - | -15.15 % | $ 60.3 M | Britain |
 |
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
-1.85 | - | 1.93 % | $ 17.4 M | USA |
 |
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | USA |
 |
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M | USA |
 |
Celldex Therapeutics
CLDX
|
-2.98 K | $ 25.84 | -5.62 % | $ 1.66 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-1.72 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-44.1 | - | 4.14 % | $ 49.1 M | USA |
 |
Cellectis S.A.
CLLS
|
-2.92 | $ 4.2 | -4.76 % | $ 116 M | France |
 |
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M | Israel |
 |
Enanta Pharmaceuticals
ENTA
|
-3.79 K | $ 12.63 | -3.66 % | $ 269 K | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.15 | - | -11.43 % | $ 502 K | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
4.82 | $ 29.04 | 4.69 % | $ 1.41 B | USA |
 |
Evogene Ltd.
EVGN
|
-0.77 | $ 1.1 | -1.0 % | $ 27.9 M | Israel |
 |
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | USA |
 |
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M | USA |
 |
Brickell Biotech
BBI
|
-1.17 | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
1.11 | $ 9.59 | 1.43 % | $ 1.55 B | Britain |
|
Foghorn Therapeutics
FHTX
|
-1.81 | $ 5.87 | 13.76 % | $ 322 M | USA |
 |
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
0.9 | $ 63.42 | -1.77 % | $ 8.48 B | USA |
 |
Arena Pharmaceuticals
ARNA
|
-10.2 | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
-0.382 | - | 3.77 % | $ 22.4 M | USA |
 |
Amicus Therapeutics
FOLD
|
0.11 | $ 14.29 | 0.04 % | $ 4.35 B | USA |